Vigonvita
China - Suzhou
BiotechnologyFocus: Small Molecule Drugs, Generics
Vigonvita is a life sciences company focused on Small Molecule Drugs, Generics.
CardiovascularNeurologyRespiratoryInfectious Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
LV232 40mg
Major Depressive DisorderClinical Trials (1)
NCT06476509A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
Phase 1VV119 Placebo （in healthy adult subjects）
SchizophreniaClinical Trials (1)
NCT06504290Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
Phase 1TPN171H
Erectile DysfunctionClinical Trials (1)
NCT06090123Drug-Drug Interaction (DDI) Study for TPN171H
Phase 1Deuremidevir Hydrobromide for Suspension
Respiratory Syncytial Virus InfectionsClinical Trials (1)
NCT06328400A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension
Phase 1TPN171H single dose
Pulmonary Arterial HypertensionClinical Trials (1)
NCT05208814A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects
Phase 1VV913 1mg group
Healthy VolunteersClinical Trials (1)
NCT07372703Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants
Phase 1Deuremidevir Hydrobromide for Suspension 100mg
Healthy SubjectsClinical Trials (1)
NCT05932459A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension
Phase 1VV261 5mg group
Healthy VolunteersClinical Trials (1)
NCT07302269Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers
Phase 1LV232/Placebo
Healthy SubjectsClinical Trials (1)
NCT06279533Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules
Phase 1TPN171H 10 mg Group
Healthy SubjectsClinical Trials (1)
NCT05750355Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers
Phase 1[14C]TPN171H
Healthy Male SubjectsClinical Trials (1)
NCT04655872Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects
Phase 1VV119
SchizophreniaClinical Trials (1)
NCT06105151Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
Phase 1VV116 200 mg Group
Healthy SubjectsClinical Trials (1)
NCT05201690Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV116 in Healthy Volunteers
Phase 1Phase 1
Clinical Trials (1)
NCT05948644The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension
Phase 1TPN171H
Erectile DysfunctionClinical Trials (1)
NCT06090136Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects
Phase 1TPN171H tablet plus alcohol
AlcoholClinical Trials (1)
NCT05316428A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects
Phase 1LV232
Healthy SubjectsClinical Trials (1)
NCT06070857Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers
Phase 1TPN171H 10mg
Erectile DysfunctionClinical Trials (1)
NCT05585931Effect of TPN171H on Spermatogenesis
Phase 1VV116 25mg Group
Healthy SubjectsClinical Trials (1)
NCT05227768Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers
Phase 1VV116
Healthy SubjectsClinical Trials (1)
NCT05221138Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers
Phase 1test formulation
Healthy ParticipantsClinical Trials (1)
NCT06749236A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension
Phase 1VV119
Healthy VolunteersClinical Trials (1)
NCT07240636Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers
Phase 1TPN171H
Erectile DysfunctionClinical Trials (1)
NCT05185011Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function
Phase 1TPN171H 2.5mg
Erectile DysfunctionClinical Trials (1)
NCT05388825Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction
Phase 2TPN171H
Erectile DysfunctionClinical Trials (1)
NCT04479917Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction
Phase 2Deuremidevir Hydrobromide for Suspension
Respiratory Syncytial Virus InfectionClinical Trials (1)
NCT06206720A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV
Phase 2Phase 2
Clinical Trials (1)
NCT04483115Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension
Phase 2LV232 40mg
MDDClinical Trials (1)
NCT06828887Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
Phase 2TPN171H 2.5mg group
Erectile DysfunctionClinical Trials (1)
NCT05188989Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
Phase 3TPN171H
Erectile DysfunctionClinical Trials (1)
NCT06301854Long-term Safety of TPN171H Tablet in Erectile Dysfunction.
Phase 3JT001
COVID-19Clinical Trials (1)
NCT05341609Efficacy and Safety of JT001 (VV116) Compared With Paxlovid
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2013
Portfolio: 31 clinical trials